Next Financial Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Next Financial Group’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$4K	Hold	1,000	–	–	﹤0.01%	2496
2021 Q3	$5K	Hold	1,000	–	–	﹤0.01%	2287
2021 Q2	$7K	Buy	+1,000	New	+$8.09K	﹤0.01%	2120
2017 Q4	–	Sell	-73	Closed	-$2K	–	1514
2017 Q3	$2K	Hold	73	–	–	﹤0.01%	1637
2017 Q2	$2K	Hold	73	–	–	﹤0.01%	1773
2017 Q1	$2K	Hold	73	–	–	﹤0.01%	1742
2016 Q4	$1K	Hold	73	–	–	﹤0.01%	2333
2016 Q3	$1K	Buy	+73	New	+$968	﹤0.01%	2326

Other funds holding PRTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Next Financial Group's PRTK Position: Q4 2021 in Review

Next Financial Group held its Paratek Pharmaceuticals, Inc. (PRTK) position steady in Q4 2021 at 1,000 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

Next Financial Group first reported a position in PRTK in Q3 2016 and has held it in 8 quarters since. The position peaked at $7K in Q2 2021. 103 funds tracked by Wall St. Rank hold PRTK as of Q4 2021.

Next Financial Group held 1,000 shares of Paratek Pharmaceuticals, Inc. worth $4K as of Q4 2021.
Next Financial Group left its Paratek Pharmaceuticals, Inc. share count unchanged in Q4 2021.
Paratek Pharmaceuticals, Inc. made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2496 holding.
Next Financial Group first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2016 and has held it in 8 quarters since.
Next Financial Group's Paratek Pharmaceuticals, Inc. position peaked at $7K in Q2 2021.
103 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.